As 2012 comes to a close, NutraIngredients looks back on an action packed year. In this gallery, we take a look at the biggest business deals of the year.
As 2012 comes to a close, NutraIngredients looks back on an action packed year. In the third of our series of galleries capturing the year’s main events, we take a look at the biggest business deals of the year.
February saw the first big acquisition of 2012, with drug giant Pfizer Inc. adding Alacer Corp., maker and distributor of Emergen-C products, to its Consumer Healthcare division for an estimated $350 million.
“We expect that our global network and deep expertise in dietary supplements combined with our desire to provide consumers with high-quality products will make Emergen-C more accessible than it has ever been before,” said Paul Sturman, President of Pfizer Consumer Healthcare.
“Emergen-C products add to and greatly complement our market-leading dietary supplement portfolio.”
Just over a month later and Schiff Nutrition splashed $150 million on Airborne Inc.
Speaking at the time of the acquisition, Tarang Amin, president and CEO of Schiff, said: “We are excited about the Airborne acquisition, which fits well with our strategy and establishes Schiff as a leader in the immune support segment.
“We believe that both Airborne and Emergen-C can be successful in the marketplace.”
The OTC immunity category is valued at over $1 billion, growing at about 3%, he said. Within this is the category of immune support, which is valued at about $0.5 billion and growing at an impressive 5 to 6%.
Copyright - Unless otherwise stated all contents of this web site are © 2015 - William Reed Business Media SAS - All Rights Reserved - Full details for the use of materials on this site can be found in the Terms & Conditions
More than 100 members of the Natural Products Association gathered in Washington, D.C., to discuss with their...
The American Botanical Council (ABC) hosted its 10th Annual Celebration and Awards Ceremony in Anaheim, California, and...
With diabetes rates rising, many healthy people are starting to consider the effects of blood glucose levels...